[{"data":1,"prerenderedAt":47},["ShallowReactive",2],{"q-nurse-106-1-basic-medicine-039":3},{"subject":4,"subjectSlug":5,"subjectFullName":6,"question":7,"related":23},"基礎醫學","basic-medicine","基礎醫學(包括解剖學、生理學、病理學、藥理學、微生物學與免疫學)",{"id":8,"webId":9,"year":10,"session":11,"subject":4,"number":12,"stem":13,"options":14,"answer":19,"answerNote":20,"images":21,"explanation":22,"freq":11},"nurse-106-1-基礎醫學-039","nurse-106-1-basic-medicine-039",106,1,39,"目前肺癌的標靶治療，最主要是針對何種基因的突變？",{"A":15,"B":16,"C":17,"D":18},"p53","K-RAS","EGFR","Her2\u002FNeu","C",null,[],"本題考點為肺癌標靶治療的主要作用基因。依分子腫瘤學,非小細胞肺癌(尤其肺腺癌)常見表皮生長因子受體 EGFR 基因突變,以 gefitinib、erlotinib 等酪胺酸激酶抑制劑抑制其訊息傳遞,是目前肺癌標靶治療最主要標的,故正解為 C。p53 為抑癌基因,突變雖普遍卻無對應成熟標靶藥,A 錯。K-RAS 突變過去缺乏有效標靶且與 EGFR 抑制劑反應差,B 非主流。Her2\u002FNeu 主要用於乳癌與胃癌標靶,D 錯。",[24,27,31,35,39,43],{"webId":25,"stem":26,"number":11,"year":10,"session":11},"nurse-106-1-basic-medicine-001","下列有關表皮的敘述，何者正確？",{"webId":28,"stem":29,"number":30,"year":10,"session":11},"nurse-106-1-basic-medicine-002","下列何者在組織學特徵上可區分為絲球帶（zona glomerulosa）、束狀帶（zona fasciculata）、網狀帶（zona reticularis）？",2,{"webId":32,"stem":33,"number":34,"year":10,"session":11},"nurse-106-1-basic-medicine-003","顴弓（zygomatic arch）是由顴骨與下列何者共同組成？",3,{"webId":36,"stem":37,"number":38,"year":10,"session":11},"nurse-106-1-basic-medicine-004","下列何者參與形成踝關節？",4,{"webId":40,"stem":41,"number":42,"year":10,"session":11},"nurse-106-1-basic-medicine-005","下列何者是維持背部直立最重要的肌肉？",5,{"webId":44,"stem":45,"number":46,"year":10,"session":11},"nurse-106-1-basic-medicine-006","行走於前臂的內側，並與上臂深層的靜脈會合成腋靜脈的是那一條血管？",6,1783840732155]